본문 바로가기
KERD
논문KCI 등재

식육에서 베타아고니스트계 약물 잔류 연구

Monitoring for β-agonist residues in raw meat in Seoul

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류수의학

초록

We investigated the residues of β-agonist (zilpaterol, ractopamine and clenbuterol) using LC-MS/MS in raw meat in Seoul. The recoveries ranged between 76.7∼89.9% in beef respectively. The limits of de-tection were 0.01∼0.09 μg/kg and the limits of quantification were 0.03∼0.28 μg/kg respectively. Residues of β-agonist drugs which exceeded maximum residue limits (MRL) were not exceed in any of the 267 samples.

Abstract

We investigated the residues of β-agonist (zilpaterol, ractopamine and clenbuterol) using LC-MS/MS in raw meat in Seoul. The recoveries ranged between 76.7∼89.9% in beef respectively. The limits of de-tection were 0.01∼0.09 μg/kg and the limits of quantification were 0.03∼0.28 μg/kg respectively. Residues of β-agonist drugs which exceeded maximum residue limits (MRL) were not exceed in any of the 267 samples.

참고문헌 (5)

  1. 식품의약품안전처, "식품공전", 식품의약품안전처고시 제 2014-194호, ~ (2014)
  2. 식품의약품안전평가원, "잔류동물용의약품 분석법 실무해설서", 229~230 (2014)
  3. 식품의약품안전처, "식품의 동물용의약품 잔류허용기준", ~ (2016)
  4. 한국육류유통수출협회, "월간육류유통수출입정보", 50~58 (2015)
  5. FDA, "CODEX Guideline for validation of Chemical Methods for the FDA Foods Program", Appendix, 2, pp.25~26 (2012)

관련 논문AI추천

이 간행물의 다른 논문 (13건)